Dynamic Causal Modeling of Preclinical Autosomal-Dominant Alzheimer's Disease

The role of high-density EEG in diagnosis and prognosis of neurological diseases: A systematic review

OBJECTIVE

The use of High-Density Electroencephalography (HD-EEG) increased in neurological disorders, due to analysis of brain connectivity. This method is able to create a detailed brain mapping. The aim is to investigate studies that employed HD-EEG in neurological and neurodegenerative filed.

METHODS

This systematic review was conducted and reported in accordance with the PRISMA. A research terms was conducted for: (1) dementia, (2) Multiple Sclerosis (MS), (3) Parkinson Disease (PD), (4) stroke, (5) epilepsy.

RESULTS

The study included a total of 89 articles: 22 dementia; 33 epilepsy; 5 MS; 24 PD; 5 S. Articles were discussed for each neurological disorder and for different types of EEG analysis: analysis of event-related potentials, specific EEG features at resting state, spectral and connectivity analysis, time-frequency analysis and EEG recordings combined with other types of intervention.

DISCUSSION

HD-EEG recordings provide evidence about the evaluation of early markers of the disease onset, mapping of cortical activity distribution of neurological disorders.

SIGNIFICANCE

HD-EEG demonstrated it effectiveness in detection of biomarkers for the diagnosis and prognosis. In dementia contributed to misdiagnosis between different subtype and identifying markers of cognitive decline, investigating motor and cognitive networks dynamics in stroke, PD and MS, and to detect task-specific network reorganization.

Combining electrodermal activity analysis and dynamic causal modeling to investigate the visual-odor multimodal integration during face perception

Objective. This study presents a novel methodological approach for incorporating information related to the peripheral sympathetic response into the investigation of neural dynamics. Particularly, we explore how hedonic contextual olfactory stimuli influence the processing of neutral faces in terms of sympathetic response, event-related potentials and effective connectivity analysis. The objective is to investigate how the emotional valence of odors influences the cortical connectivity underlying face processing and the role of face-induced sympathetic arousal in this visual-olfactory multimodal integration.Approach. To this aim, we combine electrodermal activity (EDA) analysis and dynamic causal modeling to examine changes in cortico-cortical interactions.Results. The results reveal that stimuli arising sympathetic EDA responses are associated with a more negative N170 amplitude, which may be a marker of heightened arousal in response to faces. Hedonic odors, on the other hand, lead to a more negative N1 component and a reduced the vertex positive potential when they are unpleasant or pleasant. Concerning connectivity, unpleasant odors strengthen the forward connection from the inferior temporal gyrus (ITG) to the middle temporal gyrus, which is involved in processing changeable facial features. Conversely, the occurrence of sympathetic responses after a stimulus is correlated with an inhibition of this same connection and an enhancement of the backward connection from ITG to the fusiform face gyrus.Significance. These findings suggest that unpleasant odors may enhance the interpretation of emotional expressions and mental states, while faces capable of eliciting sympathetic arousal prioritize identity processing.

A survey of brain network analysis by electroencephalographic signals

Brain network analysis is one efficient tool in exploring human brain diseases and can differentiate the alterations from comparative networks. The alterations account for time, mental states, tasks, individuals, and so forth. Furthermore, the changes determine the segregation and integration of functional networks that lead to network reorganization (or reconfiguration) to extend the neuroplasticity of the brain. Exploring related brain networks should be of interest that may provide roadmaps for brain research and clinical diagnosis. Recent electroencephalogram (EEG) studies have revealed the secrets of the brain networks and diseases (or disorders) within and between subjects and have provided instructive and promising suggestions and methods. This review summarized the corresponding algorithms that had been used to construct functional or effective networks on the scalp and cerebral cortex. We reviewed EEG network analysis that unveils more cognitive functions and neural disorders of the human and then explored the relationship between brain science and artificial intelligence which may fuel each other to accelerate their advances, and also discussed some innovations and future challenges in the end.

A Triple-Network Dynamic Connection Study in Alzheimer's Disease

Alzheimer's disease (AD) was associated with abnormal organization and function of large-scale brain networks. We applied group independent component analysis (Group ICA) to construct the triple-network consisting of the saliency network (SN), the central executive network (CEN), and the default mode network (DMN) in 25 AD, 60 mild cognitive impairment (MCI) and 60 cognitively normal (CN) subjects. To explore the dynamic functional network connectivity (dFNC), we investigated dynamic time-varying triple-network interactions in subjects using Group ICA analysis based on k-means clustering (GDA-k-means). The mean of brain state-specific network interaction indices (meanNII) in the three groups (AD, MCI, CN) showed significant differences by ANOVA analysis. To verify the robustness of the findings, a support vector machine (SVM) was taken meanNII, gender and age as features to classify. This method obtained accuracy values of 95, 94, and 77% when classifying AD vs. CN, AD vs. MCI, and MCI vs. CN, respectively. In our work, the findings demonstrated that the dynamic characteristics of functional interactions of the triple-networks contributed to studying the underlying pathophysiology of AD. It provided strong evidence for dysregulation of brain dynamics of AD.

Dynamic Causal Modeling on the Identification of Interacting Networks in the Brain: A Systematic Review

Dynamic causal modeling (DCM) has long been used to characterize effective connectivity within networks of distributed neuronal responses. Previous reviews have highlighted the understanding of the conceptual basis behind DCM and its variants from different aspects. However, no detailed summary or classification research on the task-related effective connectivity of various brain regions has been made formally available so far, and there is also a lack of application analysis of DCM for hemodynamic and electrophysiological measurements. This review aims to analyze the effective connectivity of different brain regions using DCM for different measurement data. We found that, in general, most studies focused on the networks between different cortical regions, and the research on the networks between other deep subcortical nuclei or between them and the cerebral cortex are receiving increasing attention, but far from the same scale. Our analysis also reveals a clear bias towards some task types. Based on these results, we identify and discuss several promising research directions that may help the community to attain a clear understanding of the brain network interactions under different tasks.

Persistence of information flow: A multiscale characterization of human brain

Information exchange in the human brain is crucial for vital tasks and to drive diseases. Neuroimaging techniques allow for the indirect measurement of information flows among brain areas and, consequently, for reconstructing connectomes analyzed through the lens of network science. However, standard analyses usually focus on a small set of network indicators and their joint probability distribution. Here, we propose an information-theoretic approach for the analysis of synthetic brain networks (based on generative models) and empirical brain networks, and to assess connectome's information capacity at different stages of dementia. Remarkably, our framework accounts for the whole network state, overcoming limitations due to limited sets of descriptors, and is used to probe human connectomes at different scales. We find that the spectral entropy of empirical data lies between two generative models, indicating an interpolation between modular and geometry-driven structural features. In fact, we show that the mesoscale is suitable for characterizing the differences between brain networks and their generative models. Finally, from the analysis of connectomes obtained from healthy and unhealthy subjects, we demonstrate that significant differences between healthy individuals and the ones affected by Alzheimer's disease arise at the microscale (max. posterior probability smaller than 1%) and at the mesoscale (max. posterior probability smaller than 10%).

Shaping a data-driven era in dementia care pathway through computational neurology approaches

BACKGROUND

Dementia is caused by a variety of neurodegenerative diseases and is associated with a decline in memory and other cognitive abilities, while inflicting an enormous socioeconomic burden. The complexity of dementia and its associated comorbidities presents immense challenges for dementia research and care, particularly in clinical decision-making.

MAIN BODY

Despite the lack of disease-modifying therapies, there is an increasing and urgent need to make timely and accurate clinical decisions in dementia diagnosis and prognosis to allow appropriate care and treatment. However, the dementia care pathway is currently suboptimal. We propose that through computational approaches, understanding of dementia aetiology could be improved, and dementia assessments could be more standardised, objective and efficient. In particular, we suggest that these will involve appropriate data infrastructure, the use of data-driven computational neurology approaches and the development of practical clinical decision support systems. We also discuss the technical, structural, economic, political and policy-making challenges that accompany such implementations.

CONCLUSION

The data-driven era for dementia research has arrived with the potential to transform the healthcare system, creating a more efficient, transparent and personalised service for dementia.

Biological and Cognitive Markers of Presenilin1 E280A Autosomal Dominant Alzheimer's Disease: A Comprehensive Review of the Colombian Kindred

The study of individuals with autosomal dominant Alzheimer's disease affords one of the best opportunities to characterize the biological and cognitive changes of Alzheimer's disease that occur over the course of the preclinical and symptomatic stages. Unifying the knowledge gained from the past three decades of research in the world's largest single-mutation autosomal dominant Alzheimer's disease kindred - a family in Antioquia, Colombia with the E280A mutation in the Presenilin1 gene - will provide new directions for Alzheimer's research and a framework for generalizing the findings from this cohort to the more common sporadic form of Alzheimer's disease. As this specific mutation is virtually 100% penetrant for the development of the disease by midlife, we use a previously defined median age of onset for mild cognitive impairment for this cohort to examine the trajectory of the biological and cognitive markers of the disease as a function of the carriers' estimated years to clinical onset. Studies from this cohort suggest that structural and functional brain abnormalities - such as cortical thinning and hyperactivation in memory networks - as well as differences in biofluid and in vivo measurements of Alzheimer's-related pathological proteins distinguish Presenilin1 E280A mutation carriers from non-carriers as early as childhood, or approximately three decades before the median age of onset of clinical symptoms. We conclude our review with discussion on future directions for Alzheimer's disease research, with specific emphasis on ways to design studies that compare the generalizability of research in autosomal dominant Alzheimer's disease to the larger sporadic Alzheimer's disease population.

Lateralized memory circuit dropout in Alzheimer’s disease patients

Altered connectivity within neuronal networks is often observed in Alzheimer’s disease. However, delineating pro-cognitive compensatory changes from pathological network decline relies on characterizing network and task effects together. In this study, we interrogated the dynamics of occipito-temporo-frontal brain networks responsible for implicit and explicit memory processes using high-density EEG and dynamic causal modelling. We examined source-localized network activity from patients with Alzheimer’s disease (n = 21) and healthy controls (n = 21), while they performed both visual recognition (explicit memory) and implicit priming tasks. Parametric empirical Bayes analyses identified significant reductions in temporo-frontal connectivity and in subcortical visual input in patients, specifically in the left hemisphere during the recognition task. There was also slowing in frontal left hemisphere signal transmission during the implicit priming task, with significantly more distinct dropout in connectivity during the recognition task, suggesting that these network drop-out effects are affected by task difficulty. Furthermore, during the implicit memory task, increased right frontal activity was correlated with improved task performance in patients only, suggesting that right-hemisphere compensatory mechanisms may be employed to mitigate left-lateralized network dropout in Alzheimer’s disease. Taken together, these findings suggest that Alzheimer’s disease is associated with lateralized memory circuit dropout and potential compensation from the right hemisphere, at least for simpler memory tasks.

A guide to group effective connectivity analysis, part 2: Second level analysis with PEB

This paper provides a worked example of using Dynamic Causal Modelling (DCM) and Parametric Empirical Bayes (PEB) to characterise inter-subject variability in neural circuitry (effective connectivity). It steps through an analysis in detail and provides a tutorial style explanation of the underlying theory and assumptions (i.e, priors). The analysis procedure involves specifying a hierarchical model with two or more levels. At the first level, state space models (DCMs) are used to infer the effective connectivity that best explains a subject's neuroimaging timeseries (e.g. fMRI, MEG, EEG). Subject-specific connectivity parameters are then taken to the group level, where they are modelled using a General Linear Model (GLM) that partitions between-subject variability into designed effects and additive random effects. The ensuing (Bayesian) hierarchical model conveys both the estimated connection strengths and their uncertainty (i.e., posterior covariance) from the subject to the group level; enabling hypotheses to be tested about the commonalities and differences across subjects. This approach can also finesse parameter estimation at the subject level, by using the group-level parameters as empirical priors. The preliminary first level (subject specific) DCM for fMRI analysis is covered in a companion paper. Here, we detail group-level analysis procedures that are suitable for use with data from any neuroimaging modality. This paper is accompanied by an example dataset, together with step-by-step instructions demonstrating how to reproduce the analyses.

•

This guide walks through a group effective connectivity study using DCM and PEB.

•

It explains recently developed tools for hierarchical Bayesian modelling.

•

The appendices clarify the technical detail of the PEB framework and its priors.

•

An accompanying dataset is provided with step-by-step analysis instructions.

Computational Causal Modeling of the Dynamic Biomarker Cascade in Alzheimer's Disease

Background

Alzheimer's disease (AD) is a major public health concern, and there is an urgent need to better understand its complex biology and develop effective therapies. AD progression can be tracked in patients through validated imaging and spinal fluid biomarkers of pathology and neuronal loss. We still, however, lack a coherent quantitative model that explains how these biomarkers interact and evolve over time. Such a model could potentially help identify the major drivers of disease in individual patients and simulate response to therapy prior to entry in clinical trials. A current theory of AD biomarker progression, known as the dynamic biomarker cascade model, hypothesizes AD biomarkers evolve in a sequential but temporally overlapping manner. A computational model incorporating assumptions about the underlying biology of this theory and its variations would be useful to test and refine its accuracy with longitudinal biomarker data from clinical trials.

Methods

We implemented a causal model to simulate time-dependent biomarker data under the descriptive assumptions of the dynamic biomarker cascade theory. We modeled pathologic biomarkers (beta-amyloid and tau), neuronal loss biomarkers, and cognitive impairment as nonlinear first-order ordinary differential equations (ODEs) to include amyloid-dependent and nondependent neurodegenerative cascades. We tested the feasibility of the model by adjusting its parameters to simulate three specific natural history scenarios in early-onset autosomal dominant AD and late-onset AD and determine whether computed biomarker trajectories agreed with current assumptions of AD biomarker progression. We also simulated the effects of antiamyloid therapy in late-onset AD.

Results

The computational model of early-onset AD demonstrated the initial appearance of amyloid, followed by biomarkers of tau and neurodegeneration and the onset of cognitive decline based on cognitive reserve, as predicted by the prior literature. Similarly, the late-onset AD computational models demonstrated the first appearance of amyloid or nonamyloid-related tauopathy, depending on the magnitude of comorbid pathology, and also closely matched the biomarker cascades predicted by the prior literature. Forward simulation of antiamyloid therapy in symptomatic late-onset AD failed to demonstrate any slowing in progression of cognitive decline, consistent with prior failed clinical trials in symptomatic patients.

Conclusions

We have developed and computationally implemented a mathematical causal model of the dynamic biomarker cascade theory in AD. We demonstrate the feasibility of this model by simulating biomarker evolution and cognitive decline in early- and late-onset natural history scenarios, as well as in a treatment scenario targeted at core AD pathology. Models resulting from this causal approach can be further developed and refined using patient data from longitudinal biomarker studies and may in the future play a key role in personalizing approaches to treatment.